The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)
Open accessAbstract
We have identified the zinc-finger transcription factor Kruppel-like factor 4 (Klf4) among the transcription factors that are significantly downregulated in their expression during epithelial-mesenchymal transition (EMT) in mammary epithelial cells and in breast cancer cells. Loss and gain of function experiments demonstrate that the down-regulation of Klf4 expression is required for the induction of EMT in vitro and for metastasis in vivo. In addition, reduced Klf4 expression correlates with shorter disease-free survival of subsets of breast cancer patients. Yet, reduced expression of Klf4 also induces apoptosis in cells undergoing TGFβ-induced EMT. Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct Klf4 target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), β-catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8). Thereby, Klf4 acts as a transcriptional activator of epithelial genes and as a repressor of mesenchymal genes. Specifically, increased expression of Jnk1 (Mapk8) upon down-regulation of its transcriptional repressor Klf4 is required for EMT cell migration and for the induction of apoptosis. The data demonstrate a central role of Klf4 in the maintenance of epithelial cell differentiation and the prevention of EMT and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
Research works printed but not linked: 47
- JP Thiery, 2006, Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol, 7, 131, 10.1038/nrm1835 · DOI · Paper page
- G Christofori, 2006, New signals from the invasive front, Nature, 441, 444, 10.1038/nature04872 · DOI · Paper page
- T Brabletz, 2005, Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression, Nat Rev Cancer, 5, 744, 10.1038/nrc1694 · DOI · Paper page
- S Grunert, 2003, Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis, Nat Rev Mol Cell Biol, 4, 657, 10.1038/nrm1175 · DOI · Paper page
- MA Huber, 2005, Molecular requirements for epithelial-mesenchymal transition during tumor progression, Curr Opin Cell Biol, 17, 548, 10.1016/j.ceb.2005.08.001 · DOI · Paper page
- JP Thiery, 2009, Epithelial-mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007 · DOI · Paper page
- M Yilmaz, 2011, Transcription factor Dlx2 protects from TGFbeta-induced cell-cycle arrest and apoptosis, EMBO J, 30, 4489, 10.1038/emboj.2011.319 · DOI
- F Lehembre, 2008, NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin, EMBO J, 27, 2603, 10.1038/emboj.2008.178 · DOI · Paper page
- JM Shields, 1996, Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest, J Biol Chem, 271, 20009, 10.1074/jbc.271.33.20009 · DOI · Paper page
- DT Dang, 2000, Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients, FEBS Lett, 476, 203, 10.1016/S0014-5793(00)01727-0 · DOI
- JP Katz, 2005, Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach, Gastroenterology, 128, 935, 10.1053/j.gastro.2005.02.022 · DOI · Paper page
- S Ohnishi, 2003, Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer, Biochem Biophys Res Commun, 308, 251, 10.1016/S0006-291X(03)01356-1 · doi:10.1016/s0006-291x(03)01356-1
- JL Shie, 2000, Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation, Am J Physiol Gastrointest Liver Physiol, 279, G806, 10.1152/ajpgi.2000.279.4.G806 · doi:10.1152/ajpgi.2000.279.4.g806
- H Ton-That, 1997, Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis, FEBS Lett, 419, 239, 10.1016/S0014-5793(97)01465-8 · DOI
- D Wei, 2005, Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression, Cancer Res, 65, 2746, 10.1158/0008-5472.CAN-04-3619 · DOI · Paper page
- W Zhao, 2004, Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer, Oncogene, 23, 395, 10.1038/sj.onc.1207067 · DOI · Paper page
- KW Foster, 2000, Increase of GKLF messenger RNA and protein expression during progression of breast cancer, Cancer Res, 60, 6488
- KW Foster, 2005, Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia, Oncogene, 24, 1491, 10.1038/sj.onc.1208307 · DOI · Paper page
- KW Foster, 1999, Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF, Cell Growth Diff, 10, 423
- K Akaogi, 2009, KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha, Oncogene, 28, 2894, 10.1038/onc.2009.151 · DOI
- BD Rowland, 2005, The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene, Nat Cell Biol, 7, 1074, 10.1038/ncb1314 · DOI · Paper page
- K Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- M Wernig, 2007, In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state, Nature, 448, 318, 10.1038/nature05944 · DOI · Paper page
- JA Segre, 1999, Klf4 is a transcription factor required for establishing the barrier function of the skin, Nat Genet, 22, 356, 10.1038/11926 · DOI · Paper page
- JL Yori, 2010, Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression, J Biol Chem, 285, 16854, 10.1074/jbc.M110.114546 · DOI · Paper page
- L Waldmeier, 2012, Py2T Murine Breast Cancer Cells, a Versatile Model of TGFbeta-Induced EMT In Vitro and In Vivo, PloS One, 7, e48651, 10.1371/journal.pone.0048651 · DOI
- M Deckers, 2006, The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells, Cancer Res, 66, 2202, 10.1158/0008-5472.CAN-05-3560 · DOI · Paper page
- J Bergh, 1995, Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy, Nat Med, 1, 1029, 10.1038/nm1095-1029 · DOI · Paper page
- AV Ivshina, 2006, Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer, Cancer Res, 66, 10292, 10.1158/0008-5472.CAN-05-4414 · DOI · Paper page
- C Desmedt, 2007, Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series, Clin Cancer Res, 13, 3207, 10.1158/1078-0432.CCR-06-2765 · DOI · Paper page
- X Chen, 2001, Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle, J Biol Chem, 276, 30423, 10.1074/jbc.M101194200 · DOI · Paper page
- F Yu, 2011, Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion, Oncogene, 30, 2161, 10.1038/onc.2010.591 · DOI · Paper page
- JL Yori, 2011, Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer, Neoplasia, 13, 601, 10.1593/neo.11260 · DOI
- R Li, 2010, A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, Cell Stem Cell, 7, 51, 10.1016/j.stem.2010.04.014 · DOI · Paper page
- B Derijard, 1994, JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell, 76, 1025, 10.1016/0092-8674(94)90380-8 · DOI · Paper page
- JF Santibanez, 2006, JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes, FEBS Lett, 580, 5385, 10.1016/j.febslet.2006.09.003 · DOI
- JF Alcorn, 2008, Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1, J Cell Sci, 121, 1036, 10.1242/jcs.019455 · DOI
- JL van der Velden, 2010, c-Jun N-Terminal Kinase 1 Promotes TGF-{beta}1-induced Epithelial to Mesenchymal Transition via Control of Linker Phosphorylation and Transcriptional Activity of Smad3, Am J Resp Cell Mol Biol, 47, 306
- C Huang, 2003, JNK phosphorylates paxillin and regulates cell migration, Nature, 424, 219, 10.1038/nature01745 · DOI · Paper page
- C Cellurale, 2012, Role of JNK in mammary gland development and breast cancer, Cancer Res, 72, 472, 10.1158/0008-5472.CAN-11-1628 · DOI
- C Cellurale, 2010, Role of JNK in a Trp53-dependent mouse model of breast cancer, PloS One, 5, e12469, 10.1371/journal.pone.0012469 · DOI
- P Chen, 2010, Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model, PloS One, 5, e10443, 10.1371/journal.pone.0010443 · DOI
- M Maeda, 2005, Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition, J Cell Sci, 118, 873, 10.1242/jcs.01634 · DOI · Paper page
- K Takahashi, 2007, Induction of pluripotent stem cells from fibroblast cultures, Nat Protocols, 2, 3081, 10.1038/nprot.2007.418 · DOI · Paper page
- CJ Strock, 2006, Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells, Cancer Res, 66, 7509, 10.1158/0008-5472.CAN-05-3048 · DOI · Paper page
- M Weber, 2007, Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome, Nat Genetics, 39, 457, 10.1038/ng1990 · DOI · Paper page
- VK Tiwari, 2012, A chromatin-modifying function of JNK during stem cell differentiation, Nat Genetics, 44, 94, 10.1038/ng.1036 · DOI
Cited by
The biology and role of CD44 in cancer progression: Therapeutic implications
Chen, C., Zhao, S., Karnad, A., & Freeman, J. W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0605-5 · Cited by 1,245
TGF-β Tumor Suppression through a Lethal EMT
David, C. J., Huang, Y.-H., Chen, M., Su, J., Zou, Y., Bardeesy, N., Iacobuzio-Donahue, C. A., & Massagué, J. (2016) · Cell · doi:10.1016/j.cell.2016.01.009 · Cited by 593
Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck, M., & Christofori, G. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.06.002 · Cited by 475
Self-citationEMT: Mechanisms and therapeutic implications
Singh, M., Yelle, N., Venugopal, C., & Singh, S. K. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.009 · Cited by 475
Zhou, P., Li, B., Liu, F., Zhang, M., Wang, Q., Liu, Y., Yao, Y., & Li, D. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0624-9 · Cited by 337
Metadata
- Authors
- Tiwari, N., Meyer-Schaller, N., Arnold, P., Antoniadis, H., Pachkov, M., van Nimwegen, E., & Christofori, G.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-25
- Volume
- 8
- Issue
- 2
- Pages
- e57329
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2019723293
- Cited by
- 165
- References
- 2
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-10-25)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8). https://app.cochat.ai/papers/10.1371/journal.pone.0057329
- The paper
- Tiwari, N., Meyer-Schaller, N., Arnold, P., Antoniadis, H., Pachkov, M., van Nimwegen, E., & Christofori, G. (2013). Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8). PLoS ONE. https://doi.org/10.1371/journal.pone.0057329
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.